| Literature DB >> 33282233 |
Ruiyi Fan1, Cheng Peng1, Xinxin Zhang1, Diyang Qiu1, Genlin Mao1, Yusheng Lu1, Jiwu Zeng1.
Abstract
In this study, the non-targeted large-scale plant metabolomics (UPLC-Q-Orbitrap-MS) was performed for the comparison of chemical profiling of the leaves, barks, flowers, peels, pulps, and seeds of Clausena lansium (Lour.) Skeels (called "wampee"). A total of 364 metabolites were identified, and 62 potential biomarkers were selected by the multivariate statistical analysis. Hierarchical cluster analysis suggested that the selected biomarkers were significant differential metabolites among various parts of wampee. Metabolic pathway analysis showed a significant enrichment of the "Flavone and flavonol synthesis" and "Isoquinoline alkaloid biosynthesis" pathway. This study provides important information for the isolation and identification of functional components from different tissues of wampee and the metabolic biosynthesis pathway elucidation in detail.Entities:
Keywords: Clausena lansium (Lour.) Skeels; biomarkers; comparative analysis; different tissues; non‐targeted metabolomics; wampee
Year: 2020 PMID: 33282233 PMCID: PMC7684609 DOI: 10.1002/fsn3.1841
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 2.863
FIGURE 1Base peak ion (BPI) chromatograms of different parts of wampee in positive (a) and negative (b) modes. Principal component analysis (PCA) of different parts of wampee in positive (c) and negative (d) modes
FIGURE 2Partial least squares‐discriminate analysis (PLS‐DA) of different parts of wampee in negative mode (a). Permutations plot of the PLS‐DA model for the CLL versus CLF versus CLBa versus CLPu versus CLS versus CLPe (b). Orthogonal projections to latent structures discriminant analysis (OPLS‐DA) of different parts of wampee in negative mode (c). (CLF, CLBa, CLL, CLPe, CLPu, and CLS represent the flowers, barks, leaves, peels, pulps, and seeds of wampee)
Values of the statistic parameters obtained for different OPLS‐DA models based on LC‐MS data (in negative mode)
| Model classes | OPLS‐DA | Number of DM | |||
|---|---|---|---|---|---|
| pre | R2X cum, %) | R2Y cum, %) | Q2 cum, %) | ||
| CLF versus CLL | 1+1+0 | 76.5 | 100.0 | 99.8 | 243 |
| CLF versus CLBa | 1+1+0 | 71.8 | 100.0 | 99.7 | 244 |
| CLBa versus CLL | 1+1+0 | 68.9 | 100.0 | 99.5 | 215 |
| CLPu versus CLPe | 1+1+0 | 68.6 | 100.0 | 98.8 | 212 |
| CLPu versus CLS | 1+1+0 | 63.9 | 100.0 | 99.4 | 230 |
| CLS versus CLPe | 1+1+0 | 70.2 | 100.0 | 99.3 | 235 |
| CLPe versus CLPu versus CLS | 1+1+0 | 72.2 | 99.6 | 99.1 | 194 |
| CLPu versus CLPe versus CLS versus CLF | 1+1+0 | 50.9 | 99.9 | 99.7 | 198 |
| CLPu versus CLPe versus CLS versus CLBa | 1+1+0 | 57.4 | 99.4 | 99.0 | 161 |
| CLPu versus CLPe versus CLS versus CLL | 1+2+0 | 83.3 | 99.9 | 99.6 | 175 |
| CLL versus CLF versus CLBa versus CLPu versus CLS versus CLPe | 1+2+0 | 58.9 | 99.8 | 99.6 | 140 |
Pre is the number of principal components; R2X is the model interpretability (for X variable dataset); R2Y is the model interpretability (for Y variable dataset); Q2 is the percentage of model predictability, DM means differential metabolites selected by VIP > 1, and the detailed information of the DM was provided in Table S2.
Potential biomarkers of different parts of wampee
| No. | Name | RT | Formula | CLL | CLF | CLBa | CLPu | CLS | CLPe |
|---|---|---|---|---|---|---|---|---|---|
| 1 | β‐Alanine | 91.36 | C3H7NO2 | √ | √ | √ | |||
| 2 | 4‐Pyridoxic acid | 240.83 | C8H9NO4 | √ | √ | √ | √ | ||
| 3 | Phosphorylcholine | 734.48 | C5H15NO4P | √ | √ | √ | √ | ||
| 4 | N‐Acetylglutamic acid | 96.50 | C7H11NO5 | √ | √ | √ | √ | ||
| 5 | N‐Methyltyrosine | 233.87 | C10H13NO3 | √ | √ | √ | √ | ||
| 6 | (‐)‐α‐Curcumene | 446.50 | C15H22 | √ | √ | √ | √ | ||
| 7 | Acetylcarnitine | 152.16 | C9H17NO4 | √ | √ | √ | √ | ||
| 8 | Propionylcarnitine | 306.06 | C10H19NO4 | √ | √ | ||||
| 9 | Hydroxykynurenine | 705.72 | C10H12N2O4 | √ | √ | √ | √ | ||
| 10 | Butyryl‐L‐carnitine | 389.53 | C11H21NO4 | √ | √ | √ | √ | ||
| 11 | Nicotinamide riboside | 107.58 | C11H15N2O5 | √ | √ | √ | √ | ||
| 12 | Acoric acid | 714.32 | C15H24O4 | √ | √ | √ | √ | ||
| 13 | Naringenin | 695.10 | C15H12O5 | √ | √ | √ | √ | ||
| 14 | 13‐epi‐12‐oxo Phytodienoic acid | 752.66 | C18H28O3 | √ | √ | √ | √ | ||
| 15 | (R)‐Oxypeucedanin | 579.81 | C16H14O5 | √ | √ | √ | √ | ||
| 16 | 8,11,14‐Eicosatrienoic acid | 547.13 | C20H34O2 | √ | √ | √ | |||
| 17 | Glutathione | 110.44 | C10H17N3O6S | √ | √ | ||||
| 18 | 2,3‐dinor Prostaglandin E1 | 738.23 | C18H30O5 | √ | √ | √ | |||
| 19 | γ‐Glutamyltyrosine | 342.27 | C14H18N2O6 | √ | √ | √ | |||
| 20 | 13(S)‐HpOTrE | 688.31 | C18H30O4 | √ | √ | √ | √ | ||
| 21 | Sinomenine | 674.22 | C19H23NO4 | √ | √ | ||||
| 22 | 3‐AMP | 150.27 | C10H14N5O7P | √ | √ | √ | √ | ||
| 23 | Allocholic acid | 456.61 | C24H40O5 | √ | √ | √ | √ | ||
| 24 | Delphinidin‐3‐O‐arabinoside | 537.02 | C20H19O11 | √ | √ | √ | √ | ||
| 25 | Astragalin | 524.21 | C21H20O11 | √ | √ | √ | |||
| 26 | Quercitrin | 466.07 | C21H20O11 | √ | √ | √ | |||
| 27 | Trp‐Lys‐OH | 532.42 | C23H26N4O6 | √ | √ | √ | √ | ||
| 28 | Hesperetin 7‐O‐glucoside | 462.71 | C22H24O11 | √ | √ | √ | |||
| 29 | Malvidin 3‐glucoside | 558.74 | C23H25O12 | √ | √ | √ | |||
| 30 | Leukotriene F4 | 599.90 | C28H44N2O8S | √ | √ | √ | √ | ||
| 31 | Benzene‐1,2,4‐triol | 535.46 | C6H6O3 | √ | √ | √ | |||
| 32 | Ketoleucine | 342.94 | C6H10O3 | √ | √ | √ | √ | ||
| 33 | Hypoxanthine | 201.02 | C5H4N4O | √ | √ | √ | √ | ||
| 34 | 4‐Hydroxybenzoic acid | 164.19 | C7H6O3 | √ | √ | √ | √ | ||
| 35 | Oxoglutaric acid | 165.12 | C5H6O5 | √ | √ | √ | √ | ||
| 36 | D‐beta‐Phenylalanine | 638.67 | C9H11NO2 | √ | √ | √ | √ | ||
| 37 | Gallic acid | 318.50 | C7H6O5 | √ | √ | ||||
| 38 | 4‐hydroxynonenoic acid | 818.81 | C9H16O3 | √ | √ | √ | √ | ||
| 39 | N‐Acetylleucine | 159.55 | C8H15NO3 | √ | √ | √ | √ | ||
| 40 | N‐α‐acetyllysine | 222.95 | C8H16N2O3 | √ | √ | √ | |||
| 41 | 10‐Hydroxydecanoic acid | 584.56 | C10H20O3 | √ | √ | √ | √ | ||
| 42 | Pantothenic acid | 227.10 | C9H17NO5 | √ | √ | √ | √ | ||
| 43 | Dodecanedioic acid | 476.69 | C12H22O4 | √ | √ | √ | √ | ||
| 44 | Alantolactone | 707.74 | C15H20O2 | √ | √ | √ | |||
| 45 | 5,7‐Dihydroxyflavone | 778.00 | C15H10O4 | √ | √ | ||||
| 46 | Medicarpin | 794.97 | C16H14O4 | √ | √ | √ | √ | ||
| 47 | Asp‐Phe | 274.87 | C13H16N2O5 | √ | √ | √ | |||
| 48 | Biochanin A | 775.04 | C16H12O5 | √ | √ | √ | √ | ||
| 49 | Melibiose | 232.99 | C12H22O11 | √ | √ | √ | √ | ||
| 50 | Nicotinamide ribotide | 689.10 | C11H15N2O8P | √ | √ | √ | |||
| 51 | Aesculin | 400.14 | C15H16O9 | √ | √ | √ | √ | ||
| 52 | Dehydro‐L‐(+)‐ascorbic acid dimer | 792.02 | C20H19NO5 | √ | √ | √ | √ | ||
| 53 | Parfumine | 326.34 | C15H16O11 | √ | √ | ||||
| 54 | Secoisolariciresinol | 590.04 | C20H26O6 | √ | √ | √ | √ | ||
| 55 | Linustatin | 406.43 | C19H28O11 | √ | √ | √ | √ | ||
| 56 | Deoxycholic acid | 815.64 | C24H40O4 | √ | √ | √ | √ | ||
| 57 | Quercetin 3‐arabinoside | 531.68 | C20H18O11 | √ | √ | √ | √ | ||
| 58 | Raffinose | 514.83 | C18H32O16 | √ | √ | ||||
| 59 | dTDP‐3‐O‐methyl‐beta‐L‐rhamnose | 399.53 | C17H28N2O15P2 | √ | √ | √ | √ | ||
| 60 | NAD | 218.69 | C21H28N7O14P2 | √ | √ | √ | √ | ||
| 61 | Quercetin 3‐(2G‐xylosylrutinoside) | 450.79 | C32H38O20 | √ | √ | √ | |||
| 62 | p‐Coumaroyl‐CoA | 413.78 | C30H42N7O18P3S | √ | √ | √ | √ |
FIGURE 3Heatmap of hierarchical clustering analysis of differential metabolites selected as the biomarkers in different parts of wampee. The abscissa indicates different groups labeled with different color for the main groups and numerically marked for the subgroups. The ordinate indicates the differential metabolites selected as the potential biomarkers in different parts of wampee. The bar at the right of the heat map represents relative expression values
FIGURE 4Pathway analysis of differential metabolites for CLF versus CLL (a), CLF versus CLBa (b), CLBa versus CLL (c), CLPu versus CLPe (d), CLPu versus CLS (e), CLS versus CLPe (f), CLPu versus CLPe versus CLS (g), CLPe versus CLPu versus CLS versus CLF (h), CLPe versus CLPu versus CLS versus CLBa (i), CLPe versus CLPu versus CLS versus CLL (j), CLL versus CLF versus CLBa versus CLPe versus CLPu versus CLS (k). (CLF, CLBa, CLL, CLPe, CLPu, and CLS represent the flowers, barks, leaves, peels, pulps, and seeds of wampee) Each bubble in the plot represents a metabolic pathway whose abscissa and bubble size jointly indicate the magnitude of the impact factors of the pathway in the topological analysis. The bubble ordinates and colors represent the p values (negative natural logarithm, i.e., −log p‐value) of the enrichment analysis, with darker colors showing a higher degree of enrichment. The most significant pathway was labeled